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ABSTRACT 
 Studies in animals and humans link both physical and psychological stress with 
an increased rate and severity of infections and onset of diseases. Stress is a very broad 
and complex topic.  It can be defined as a condition occurring in response to adverse 
external influences capable of affecting physical health which leads to activation of a 
stress response in the body.  There are two prominent stress responsive systems:  the 
hypothalamic-pituitary-adrenal axis and the sympathetic adrenomedullary axis.  These 
systems are responsible for the majority of the changes in the body, which occur in 
response to stress.  Stress has been linked to many detrimental effects in cattle including 
immune suppression, increased disease susceptibility and decreased reproduction.  
These cause huge economic losses to the cattle industry every year.  Weaning has been 
identified as one of the main stressors implicated in these negative effects.  For this 
reason it is important to be able to identify animals stressed by weaning and do so using 
samples which are easily obtainable and useful for future diagnostic purposes. We 
hypothesize that weaning will cause sufficient stress in cattle to alter protein profiles in 
serum, which can be used to identify this type of stress.  To do this we employed 
proteomic methodologies including two-dimensional gel electrophoresis and mass 
spectrometry to compare an abrupt weaned group of calves to a never weaned group and 
a previously weaned group (preconditioned).  We have included a preconditioned group 
to examine the differences between this group and animals which have never been 
weaned.  Preconditioned animals are typically used as a control group in weaning 
studies.  A total of 83 distinct protein bands were identified after image analysis.  Out of 
83 protein bands, we found 9 spots which were significantly different in abundance 
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among the treatment groups.  Two out of 9 spots were significantly different between 
the abrupt weaned and the never weaned groups.  Five protein bands were also found to 
be significantly different between the abrupt weaned group and the preconditioned 
group.  Five protein bands were found to be significantly different between the never 
weaned group and the preconditioned group.  Identification of these proteins, however, 
had limited success since the bovine protein database is not as extensive as that for 
humans or mice.  Among the proteins identified were alpha-1-acid glycoprotein and 
collagen precursor.  The differences in intensities found between the abrupt weaned 
group and the never weaned group may be useful as markers of calves going through 
weaning stress.  We have also seen that animals who have undergone weaning and 
through the stress associated with that event are not exactly the same as animals which 
have never been weaned.  This has implications to research where a preconditioned 
group is used as a control rather than a never weaned group. Despite the limitations of 
the methodology used for the current system, the overall results revealed specific 
changes in serum proteins which were associated with abrupt weaned animals.  Future 
studies can be planned to determine the specificity of these protein changes and possibly 
identify the molecular basis of stress dependent disease susceptibility. 
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1.0 INTRODUCTION 
Stress is a very broad concept and difficult to define in a concise way which 
captures all of its connotations.  Griffin (1989) reports that in the early 20th century Hans 
Seyle proposed the general adaptation syndrome which provided the first comprehensive 
biological theory of stress.  In a veterinary context this was identified as an abnormal or 
extreme adjustment in the physiology of the animal to cope with adverse effects of its 
environment and management (Fraser et al. 1975).  It is clear that stress can be defined 
in many different ways depending upon the objectives or perspective of the researcher.  
For our purposes, stress is defined as a condition occurring in response to adverse 
external influences capable of altering physiological responses.  Many types of stressors 
can contribute to this condition including psychological stressors and physical stressors.  
In situations where an individual is crowded, isolated, transported or introduced to a 
new environment, it can experience psychological stress.  In circumstances where an 
individual is exposed to extreme temperatures or forced exercise, physical stress can be 
induced.  In many cases, a stressor can be composed of both a psychological component 
as well as a physical component.  Such is the case when exposed to painful situations, 
restraint or during weaning. 
 There are two main systems that respond to stress in the body:  the 
hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic adrenomedullary 
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(SAM) system (Van de Kar et al. 1999; Elenkov et al. 2000).  Both act to prepare the 
body for what is commonly known as the fight or flight response.  Since the body 
perceives a stressor as something which decreases the probability of survival, the fight 
or flight response is necessary to combat it. These stress responsive systems act through 
a cascade of stress hormones which activate or inhibit the appropriate responses 
(Elenkov et al. 2000).  Such responses include increased cardiovascular output, 
decreased appetite, increased energy to the brain and muscles as well as changes in 
immune function (Stratakis et al. 1995; Habib et al. 2001).  These responses are 
important when survival is at risk but, unfortunately, their effects may not always 
benefit the body. 
 Many harmful effects of stress have been reported in the literature for both 
humans and other animals.  For humans, stress contributes to cardiovascular disease, 
learning impairment, and insulin resistance among other things (Straub et al. 2005; 
Black 2006; Brydon et al. 2006).  For animals such as cattle, reproduction and fertility 
are negatively affected by heat stress (Wolfenson et al. 2000).  Stress has also been 
implicated in decreased weight gain and quality of meat (Trunkfield et al. 1990; Shaefer 
et al. 1997).  The aforementioned effects have an impact on the health of the individual 
as well as industries pertaining to the production of animals; however, the effects of 
stress on the immune system have by far the greatest impact of all (Yang et al. 2000; 
Padgett et al. 2003).  Stress has been shown to alter immune function in ways which can 
lead to increased susceptibility to infection as well as severity of disease (Yang et al. 
2000).  This has been demonstrated in many species including humans, cattle and mice 
(Glaser et al. 1992; Galyean et al. 1999; Mineur et al. 2006).  It is important to study 
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stress and how it causes its many effects in order to gain a complete understanding of 
the mechanisms and to help prevent or combat these negative repercussions. 
 In order to study stress, there must be a clear and simple way of identifying it.  
The term biomarker denotes a substance used as an indicator of a biologic state.  This 
can be very useful when identifying and defining a condition such as stress.  It has been 
observed that cortisol concentrations, both serum cortisol as well as salivary, change in 
response to stressful conditions (Beerda et al. 1996).  This would suggest that it could be 
used as a biomarker for stress.  Many studies have used cortisol as a biomarker of stress.  
Cortisol levels increased above normal concentrations are a good indicator that the 
animal is considered to be stressed (Grandin 1997).  However, when studying certain 
types of stressors, such as weaning in cattle, cortisol is unreliable when samples are 
collected once a day (Hickey et al. 2003).  To detect significant changes in 
concentration, cortisol levels must be monitored more frequently (Queyras et al. 2004).  
For example, sampling on an hourly basis may be more revealing but hourly sampling is 
impractical when dealing with animals such as calves.  The extra handling for sample 
collection can add to the stress of the calf as the restraint and human contact are 
powerful psychological stressors; therefore, there is a great need for a more practical, 
reliable and consistent indicator of stress. 
 Weaning has long been identified as a stressor.  This has many implications 
especially to the cattle industry because it has been linked to stress-related immune 
suppression (Hickey et al. 2003).  The alteration in immune function caused by stressors 
has been shown to lead to increased disease susceptibility (Yang et al. 2000).  Bovine 
respiratory disease (BRD) has a huge economic impact due to animal loss, decreased 
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weight of calves and the cost associated with treating this illness (Fike et al. 2006).  
Weaning is recognized as a major contributing factor to BRD (Galyean et al. 1999).  It 
is important to study weaning as a stressor in order to determine its effects and the 
mechanisms through which it exerts these effects.  This knowledge may identify 
effective strategies to prevent or treat related illnesses.  The first step is to discover a 
novel way of identifying weaning stressed animals perhaps by identifying a group of 
candidate biomarkers and characterizing their pattern of change.  These candidate 
biomarkers or their pattern could be validated clinically to establish them as important 
biomarkers and could then be used in future studies as well as to eventually develop a 
diagnostic tool. 
With these goals in mind, the effects of weaning stress were studied in serum 
from young calves to identify potential candidate biomarkers. 
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2.0 BACKGROUND 
2.1 Types of Stressors  
Stressors can be separated into three main types:  psychological stressors, 
physical stressors and a combination of both. 
 
2.1.1 Psychological Stressors 
 A psychological stressor is something which does not physically affect the body 
directly but is perceived as stressful or dangerous.  The individual perceives it as 
dangerous or bothersome and in so doing creates a stress response.  This type of stressor 
induces various stress responses in the body and somehow through this exerts its 
physiological effects.  There are numerous examples of this type of stressor identified in 
the literature.  For humans, psychological stress can be caused by work, exams, social 
situations or any life event that is perceived as a significant change .  For animals, 
psychological stress can be caused by transportation (Arthington et al. 2003), handling 
(Grandin 1997), mixing or isolation (Kelley 1980), threat from a predator and many 
other situations.  Psychological stress has been studied in regards to its physiological 
effects in cattle (Veissier et al. 2001).   
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2.1.2 Physical Stressors 
 A physical stressor is one which affects the body directly.  This type of stressor 
also induces stress responses in the body.  Included in this category are stressors such as 
heat and cold stress, limit-feeding and exercise (Kelley 1980).  This group of stressors 
affects humans and animals alike. 
 
2.1.3 Combination Stressors 
 Some stressors have both a psychological component as well as a physical 
component.  This is the case for stressors such as noise, pain, restraint and weaning 
(Kelley 1980).  Weaning stress, for example, is composed of severing the maternal bond 
which is a psychological stress and a nutritional change which is a physical stress.   
 
2.2 Stress responsive systems 
 When an individual experiences a stressful stimulus, acquired sensory 
information is routed through the thalamus or reticular activating system to the 
amygdala and sensory cortex (Van de Kar et al. 1999; Carrasco et al. 2003).  The 
sensory cortex relays this information to the lateral amygdala via the perirhinal cortex 
directly or the hippocampus then the perirhinal cortex.  The amygdala is implicated in 
endocrine, autonomic and behavioral responses.  It innervates both the 
catecholaminergic nuclei and the raphe nucleus which in turn innervate corticotrophin-
releasing hormone neurons located in the hypothalamic paraventricular nucleus. 
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2.2.1 Hypothalamic-pituitary-adrenal axis 
 The hypothalamus is the starting point of the hypothalamic-pituitary-adrenal 
axis.  This axis is one of two stress responsive systems responsible for the changes that 
take place in the body after experiencing stressors.  Corticotropin-releasing hormone 
(CRH) is synthesized by the parvicellular neurons in the paraventricular nucleus of the 
hypothalamus (Van de Kar et al. 1999; Carrasco et al. 2003).  Vasopressin and oxytocin 
are synthesized in the magnocellular subdivision of the paraventricular nucleus.  CRH 
and vasopressin are released together into the portal circulation where they stimulate 
adrenocorticotropin hormone (ACTH) release from the anterior lobe of the pituitary 
gland.  Release of ACTH occurs only 10 seconds after stimulus (Sapolsky 2000; 
Carrasco et al. 2003) and serves to regulate the secretion of glucocorticoids from the 
adrenal glands.  Glucocorticoids play a role in homeostasis, energy metabolism, growth 
processes as well as immune and brain function (Stratakis et al. 1995; Habib et al. 
2001).  They do so through interaction with two glucocorticoid receptor subtypes:  
glucocorticoid receptor (GR) and mineralocorticoid receptor (MR).  MRs are present in 
limbic neurons and GRs are widespread throughout the brain including negative 
feedback sites in the hypothalamus and pituitary gland (de Kloet 1995).  Both subtypes 
function as transcription factors which are ligand-dependent (Carrasco et al. 2003).  An 
example of a glucocorticoid is cortisol.  Stimulation of the adrenal cortex to release 
cortisol is the end-point of the hypothalamic-pituitary-adrenal axis (HPA).  Cortisol goes 
on to mediate many functions in the body and completes a negative feedback loop at the 
hypothalamus and pituitary gland. 
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 It has been observed that certain cytokines from an immune response can 
activate the HPA (Besedovsky et al. 1986; Chrousos 1995; Elenkov et al. 2000).  These 
cytokines include tumor necrosis factor alpha (TNF-α), interleukin-1 (IL-1) and 
interleukin-6 (IL-6).  How they stimulate the release of CRH and ACTH is unclear but 
these hormones are present in higher quantities in response to circulating cytokines.  
Since the hypothalamus and pituitary are protected by the blood-brain barrier, it is 
thought that their activation is achieved through activation of the peripheral and central 
nervous systems (Chrousos 1995). 
 
2.2.2 Sympathetic adrenomedullary system 
 The autonomic nervous system is also activated in response to stressful stimuli.  
The sympathetic subdivision is responsible for many changes in the body associated 
with the fight or flight response.  This begins in a group of sites in the medulla and pons 
of the brainstem which are collectively known as the locus coeruleus/norepinephrine 
system (LC/NE) (Elenkov et al. 2000).  These sites include noradrenergic cell groups as 
well as the locus coeruleus of the pons (Fisher 1989).  Neurons containing CRH are 
present in many sites of the brain outside the hypothalamus including the LC/NE system 
(Fisher 1989; Tsigos et al. 2002).  Stress stimulates the release of CRH from these 
neurons although many of the mechanisms are unclear (Tsigos et al. 2002).  CRH 
functions as a hormone in the HPA but it has been observed that it can also play the role 
of neurotransmitter in other locations (Fisher 1989; Fisher et al. 1991; Minton 1994).  
One such location is the LC/NE system.  Here CRH serves to activate noradrenergic 
neurons (Arlt et al. 2003), which stimulate the release of norepinephrine (NE) in several 
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parts of the brain (Elenkov et al. 2000).  NE is the major neurotransmitter of the 
sympathetic nervous system (SNS).  Elenkov et al (2000) reviewed the physiology of 
the SNS quite simply and concisely.  They stated that the SNS begins in the central 
nervous system (CNS), specifically with cell bodies in the brainstem and spinal cord.  
From there, preganglionic efferent nerve fibres extend down the spinal cord and exit 
through thoracic and lumbar spinal nerves, which are known as the thoracolumbar 
system.  These preganglionic fibres end at ganglia located in the paravertebral chains on 
either side of the spinal column as well as prevertebral ganglia in front of the vertebrae.  
Postganglionic fibres run from the ganglia and innervate tissue throughout the body.  
Most of these postganglionic fibres act by releasing NE.  Some sympathetic 
preganglionic fibres do not end in ganglia and extend to glands such as the adrenal 
medulla.  Chromaffin cells in the medulla are innervated by preganglionic nerve 
terminals, which use acetylcholine as their neurotransmitter.  When the SNS is 
activated, the adrenal medulla is stimulated to release epinephrine (E) and NE although 
E is released in much greater quantities. 
Catecholamines (CAs) are involved in many aspects of the fight or flight 
response including the release of energy or fuel metabolism, cardiovascular effects such 
as increased heart rate and blood vessel tone, thermogenesis and immunomodulation 
(Elenkov et al. 2000; Kohm et al. 2001; Lundberg 2005).  Sympathetic nerve fibres 
innervate many organs important to the immune system including; spleen, thymus, bone 
marrow, lymph nodes and mucosa-associated lymphoid tissue (Elenkov et al. 2000).  
Within these organs, the nerve fibres end in what are called varicosities.  This is an end 
of the fibre without cell contact or a synapse.  They release NE which diffuses to the 
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immune cells and interacts with them via adrenoreceptors setting off specific signal 
transduction pathways within the cells.  An example of this is the inhibition of dendritic 
cell migration, decreased antigen presentation and decreased T helper cell type 1 
priming in dendritic cells (DCs) (Chrousos 1995; Maestroni 2005).  These processes are 
mediated through the interaction of NE with β-adrenergic receptors on the DC surface. 
The sympathetic adrenomedullary system (SAM) and the HPA work together to 
ensure homeostasis is maintained.  It is not surprising then that they also communicate 
between each other.  Neurons containing CRH run from the paraventricular nucleus 
(PVN) of the hypothalamus to the brainstem and likewise, neurons containing CAs can 
be traced from the LC/NE to the PVN along the ascending noradrenergic bundle 
(Chrousos et al. 1992; Elenkov et al. 2000).  This ensures that activation of one system 
triggers the activation of the other. 
As with the HPA, the sympathetic adrenomedullary system can also be activated 
by circulating cytokines during an immune response (Chrousos 1995; Elenkov et al. 
2000).  They act as a negative feedback loop between the immune system and the brain.  
In response to these cytokines, both stress systems are activated and work to inhibit 
many aspects of the immune response.  The presence of this feedback loop may serve to 
keep immune responses such as inflammation in check and not allow them to get out of 
control.   
Although the physiology of induction of HPA and SAM and the effects of stress 
are complex subjects and many aspects still need to be explored at length, the 
aforementioned is a synopsis of the overall knowledge relevant to work in this thesis. 
Since cattle were used as a model in this work, I would like to introduce the subject of 
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stress and its effects in terms of cattle followed by a brief overview of the topic in 
humans. 
 
2.3 Effects on Cattle 
The effects of several types of stressors have been studied in relation to cattle.  
Stress in cattle is very important because it has been linked to decreased reproduction, 
decreased meat quality, disease susceptibility as in the case of bovine respiratory disease 
and more (Kelley 1980; Tarrant 1990; Trunkfield et al. 1990; Shaefer et al. 1997; Fike 
et al. 2006).  All of these conditions contribute to huge economic losses in the cattle 
industry every year (Fike et al. 2006).  Among the most studied stressors are weaning, 
heat stress, and transport.  Weaning and transportation have been indicated as two of the 
most important stressors that cattle can experience (Johnson et al. 1976; Kelley 1980).  
There is extensive literature on the effects of transportation on cattle. 
 
2.3.1 Transportation 
The effects of all stages of transportation on cattle are well documented in the 
literature.  Transportation stress includes the effects of handling during loading and 
unloading, removal from familiar environment and placement into a novel environment, 
mixing with unfamiliar animals, changing temperature, and deprivation of food and 
water as well as weaning depending on the age of the calves (Trunkfield et al. 1990).  
Stress in general is known to be an immunosuppressant (Kelley 1980).  This is also the 
case for transport stress in cattle.  Fike and Spire (2006) reported that cattle which have 
been transported have a decrease in lymphocytes and an increase in neutrophils in the 
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blood.  They also reported a decrease in antibody responses three days after transport 
and a decrease in lymphocyte blastogenesis in calves after transport (Fike et al. 2006).  
Perhaps an explanation for the connection between transport and bovine respiratory 
disease is the effects of this stress on the cells in the lung.  Macrophages and 
lymphocytes in bronchoalveolar fluid from young calves were changed in number and 
function after short-term transport (Ishizaki et al. 2005).  Lowered immunity in the lung 
could contribute to the onset of respiratory diseases. 
Transport has been shown to elevate cortisol levels in calves (Johnson et al. 
1976; Trunkfield et al. 1990).  Some studies have attempted to break transportation 
down into its aforementioned components.  Loading and unloading have proved to be 
the most stressful components (Kent et al. 1983; Trunkfield et al. 1990).  This is most 
likely due to the physical exertion, noise and human contact.  Cortisol has been shown 
to increase during the first two hours of transportation and stabilize over longer trips 
(Kent et al. 1983).  This suggests that the most stressful event is loading at the 
beginning of transport.  Even human contact alone raises the heart rate of an animal 
(Stephens et al. 1974).  Elevations in glucocorticoids decrease as calves become 
accustomed to human contact and handling (Crookshank et al. 1979).  In addition to 
loading, introduction to a new environment, social mixing, animal density and length of 
journey have been studied individually and have been associated with the induction of 
stress and increased cortisol (Trunkfield et al. 1990). 
It has been reported that transportation has also been shown to reduce live 
weight, reduce carcass yield and lower meat quality (Shaefer et al. 1997).  A condition 
known as dark, firm and dry meat (DFD) occurs with greater frequency after an animal 
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has been stressed (Trunkfield et al. 1990).  DFD is caused by muscle glycogen store 
depletion before death.  DFD reduces the quality of meat and therefore, creates 
economic losses in the beef industry.  If there were a method or tool to indicate which 
animals were stressed before slaughter, then stressed animals could be put aside to 
regenerate glycogen and reduce the incidence of DFD.  Reducing the stress involved in 
all aspects of transportation would be highly beneficial to the beef industry.  It would 
improve the welfare of the animals as well as reduce economic losses. 
 
2.3.2 Weaning 
There has been limited research on the effects of weaning alone on cattle.  The 
majority of the literature focuses on weaning and transportation together since often 
both of these stressors occur at around the same time in a farm setting.  However, abrupt 
weaning is known to cause stress in calves and is therefore an important area to study 
further (Kelley 1980).  The few studies on weaning alone have identified some 
interesting effects.  It has been observed that weaning alone does not increase cortisol 
levels in calves (Lefcourt et al. 1995; Hickey et al. 2003).  This would suggest that 
another method of identifying weaning stress is required since changes in cortisol levels 
do not appear to apply to weaning stress.  Epinephrine and norepinephrine levels were 
also measured to assess the activation of SAM.  Epinephrine levels did not change 
however, norepinephrine increased compared to controls (Lefcourt et al. 1995; Hickey 
et al. 2003).  Hickey et al (2003) also found that weaning stress altered the 
neutrophil:lymphocyte (N:L) ratio increasing the proportion of neutrophils.  Changes in 
the N:L ratio is thought to be a potential biological indicator of stress and disease 
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susceptibility.  One detail to note about the study by Hickey et al (2003) is that the 
calves were not only weaned from the dams but were kept in isolation after the abrupt 
weaning.  Since isolation is also a stressor, this may act in part as a confounding 
variable.  Thus, there is a lack of research specifically addressing weaning stress.  
Further studies are required to augment our knowledge of this stressor and its effects on 
calves.   In addition, since cortisol levels do not appear to change in response to 
weaning, another marker is required. 
 
2.3.3 Heat Stress in Dairy Cattle 
There is a large body of literature on the effects of heat stress on the 
reproduction of dairy cattle (Wolfenson et al. 2000; De Rensis et al. 2003; Garcia-
Ispierto et al. 2006).  Heat stress in the summer months lowers the conception rate of 
lactating dairy cows from 40-60% to 10-20% (Wolfenson et al. 2000).  This creates 
huge economic losses to the dairy industry.  Heat stress has both direct and indirect 
effects on cattle reproduction.  These direct effects on the reproductive process are 
considered to be the predominant cause of low conception rates (Wolfenson et al. 2000).  
Indirect effects include redistribution of blood flow among body organs and a reduction 
in food intake.  The direct effects of heat stress include changes in cellular functions of 
different tissues and parts of the reproductive system (Wolfenson et al. 2000).  
Specifically, it negatively affects the preovulatory follicle, developing embryo in early 
stages, corpus luteum, uterine endometrium and anterior pituitary.  The net result is low 
fertility and also the loss of fetuses. 
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In an attempt to measure the amount of heat stress cattle can endure, a 
calculation called the temperature-humidity index (THI) is used (Garcia-Ispierto et al. 
2006).  This is a measure of heat comfort.  Heat stress is defined as a THI over 72 units 
(Garcia-Ispierto et al. 2006).  Garcia-Ispierto et al (2006) reported a correlation between 
a high THI value on days 21-30 of gestation and fetal loss.  There are no reports in the 
literature regarding cortisol measurement during heat stress. 
 
2.3.4 Social Reorganization 
Social reorganization of cattle is a psychological stressor (Kelley 1980).  As a 
stressor, it has rarely been studied alone.  Only two studies focused on social mixing 
stress by itself (McVeigh et al. 1982; Veissier et al. 2001).  Vessier et al (2001) reported 
that it is a common farm practice to periodically reorganize cattle into new groups based 
on weight gain and feed rations.  Since this social mixing is a known stressor, this is a 
questionable practice.  It may cause unnecessary negative effects on meat quality and 
animal welfare.  McVeigh et al (1982) found that social mixing decreased the muscle 
glycogen and recovery of glycogen stores was slow.  They also observed increases in 
body temperature and heart rate following social reoganization.  After multiple mixes, 
Veissier et al (2001) reported no change in cortisol levels between mixed animals and 
controls.  However, the two treatment groups did differ in their response to 
dexamethasone injection.  Mixed animals showed an increased level of cortisol after 
dexamethasone injection versus before injection.  Behavioral observations were also 
recorded in this study and the majority of the differences between the mixed animals and 
controls occurred only after the first mixing.  In addition to social mixing in the farm 
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setting, transportation involves many instances of social reorganization.  Therefore, 
studies on transportation of cattle also include a component of social reorganization. 
Important stressors and their impacts on cattle have been reviewed; however, 
these stressors along with other stressors are also important in humans although the end 
responses may be different. 
 
2.4 Effects of Stress on Human Health 
Stress can also have negative effects on human health.  Some very common 
human disorders may have a causative component of stress.  The following are a few 
examples of how stress can negatively affect the human population. 
 
2.4.1 Cardiovascular Diseases 
Stress has been associated with increased risk of cardiovascular diseases such as 
acute coronary events, atherosclerosis and hypertension.  Many studies have made the 
observation that psychological stress contributes to the development of these diseases; 
however the mechanisms remain elusive.  Atherosclerosis or coronary heart disease is a 
hardening of the arteries due to plaque formation.  The result is a narrowing of the 
arteries which leads to insufficient blood supply to the organ.  In the case of the heart, 
insufficient blood supply causes myocardial infarction or a heart attack.  High fat diets, 
inactivity and high blood pressure are well known risk factors for coronary heart disease 
(CHD) but lately connections have been made between psychological stress and CHD 
(Manuck et al. 1988; Allen et al. 1995; Rozanski et al. 1999; Girod et al. 2004; Brydon 
et al. 2006). 
  17
One mechanism by which stress is thought to contribute to CHD is 
hemoconcentration (Allen et al. 1995).  This process can contribute to many 
cardiovascular system problems including stroke, myocardial infarction, cardiac 
ischemia and atherosclerosis.  Hemoconcentration is caused by a decrease in blood 
plasma volume as well as an increase in hematocrit.  This occurs in response to stressful 
stimuli.  It is known that catecholamines cause both an increase in blood pressure and an 
increase in venous tone and resistance.  Therefore, in response to stress, fluid is forced 
from the blood into interstitial spaces and the plasma volume drops.  This increase in 
blood viscosity is what contributes to the formation of plaques on the arterial walls as 
well as the aforementioned cardiovascular diseases. 
Personality type is thought to play a role in CHD as well.  People with a type A 
personality are prone to competitiveness, hostility and anger.  It is these traits that are 
major risk factors in CHD because they would induce greater stress in the individual 
than a more relaxed personality (Manuck et al. 1988).  These type A individuals 
demonstrate more hemodynamic properties when stressed and are therefore at more risk 
for CHD.  The sympathetic nervous system is thought to play a role in CHD because it 
is observed in monkeys that dominant individuals have an increase in atherosclerosis 
which can be inhibited by β-adrenergic blockers (Manuck et al. 1988). 
In addition to acute psychological stress, psychosocial factors such as 
depression, work-related stress (job strain) and chronic stress have all been linked with 
an increased risk of atherosclerosis (Rozanski et al. 1999).  Depression is known to 
induce hypercortisolemia due to increased activation of the HPA.  Depression is 
associated with impairments in platelet function, which produce proatherogenic effects.  
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Platelets are now thought to be critical in the development of atherosclerosis (Brydon et 
al. 2006).  Atherosclerosis is a chronic inflammatory process involving leukocytes and 
endothelium of the arteries (Ross 1999).  Platelets facilitate the interaction between 
leukocytes and the artery wall.  When platelets are activated, P-selectin is increased on 
their surface (Merten et al. 2004).  P-selectin binds to P-selectin glycoprotein ligand-1 
(PSGL-1) which facilitates both an interaction with leukocytes to form platelet-
leukocyte aggregates (PLAs) as well as the rolling of platelets and leukocytes on the 
endothelium of the arteries (Merten et al. 2004; Brydon et al. 2006).  The recruitment of 
leukocytes to the endothelium results in an increased lesion size.  It is believed that 
dysfunctional endothelial cells, inflammation and the recruitment of leukocytes all 
contribute to the formation of lesions (Huo et al. 2003).  In addition to the changes to P-
selectin, activated platelets also release an increased amount of adhesive and pro-
inflammatory factors to the leukocytes and endothelial cells (Huo et al. 2004).  These 
factors include chemoattractants to recruit leukocytes, monocytes, fibroblasts and 
vascular smooth muscle cells to the endothelial wall (Huo et al. 2004; Brydon et al. 
2006).  These cells are stimulated to proliferate in the lesions.  Monocytes in these 
lesions produce inflammatory cytokines and free radicals.  Activated platelets also 
express CD40 ligand (CD40L), which binds to CD40 on the endothelial cells and 
upregulates chemokines and adhesion molecules further recruiting leukocytes to the site 
(Brydon et al. 2006).  This whole process contributes to the progression of 
atherosclerosis.  Stress and psychosocial factors are thought to participate in the 
progression of atherosclerosis by activating platelets.  PLA formation increases and 
these complexes last longer in the circulation after stress (Brydon et al. 2006).  The 
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exact mechanisms of the effects of stress on PLA formation are unclear but it has been 
observed that catecholamines can stimulate the activation of platelets (von Kanel et al. 
2000; Steptoe et al. 2003; Brydon et al. 2006); however there are studies to the contrary.  
The evidence that acute stressors affect atherosclerosis is inconsistent and further 
research is required (Steptoe et al. 2003). 
 
2.4.2 Insulin Resistance and Type-2 Diabetes 
Diabetes mellitus type 2 (T2D) is a disease characterized by insulin resistance 
(IR) and hyperglycemia.  Insulin is the protein responsible for the regulation of glucose 
uptake and metabolism.  Insulin resistance is a disorder where the individual’s cells have 
a decreased sensitivity to insulin.  This decreased sensitivity leads to a decreased ability 
of insulin to activate metabolism of glucose, increased plasma concentrations of insulin, 
dyslipidemia (decreased plasma triglycerides and decreased high density lipoprotein 
cholesterol) and hyperglycemia, which is a large increase in circulating glucose (Black 
2006).  Stress has been implicated as one of many contributing factors to IR and T2D 
(Pliquett et al. 2004; Black 2006).  It has been observed that catecholamines can induce 
a decreased activation of the insulin receptor (Pliquett et al. 2004; Black 2006).  This is 
very obvious in the case of pheochromocytoma patients.  This disorder induces high 
catecholamine production and very low sensitivity to insulin (Pliquett et al. 2004).  One 
mechanism by which stress can act to induce insulin resistance is by inhibiting insulin 
signaling molecules such as insulin receptor substrate-1 (IRS-1) and insulin receptor 
substrate-2 (IRS-2) (Klein et al. 1999).  Insulin binding to its receptor activates a 
signaling cascade inside the cell (Klein et al. 1999).  The receptor induces 
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phosphorylation of several substrates including IRS-1 and IRS-2.  These substrates then 
interact with Src homology-2 (SH-2) domain containing protein phosphatidylinositol 3-
kinase (PI-3 kinase).  PI-3 kinase leads to the activation of Akt and stimulates active 
glucose uptake (Klein et al. 1999).  It is by SNS activation (β-adrenergic stimulation) 
that this cascade is inhibited.  Phosphorylation of IRS-1 and to a lesser extent IRS-2 is 
decreased and PI-3 kinase activity is suppressed therefore, glucose uptake is diminished 
and insulin sensitivity of the cell is decreased (Klein et al. 1999).  Insulin can also 
activate the SNS creating a positive feedback loop which further increases IR (Pliquett 
et al. 2004).  There is an ongoing epidemic of diabetes mellitus type 2 in North America 
and along with obesity, inactivity and hypertension; stress is contributing to the onset of 
this disease. 
 
2.4.3 Rheumatoid Arthritis and Juvenile Idiopathic Arthritis 
Rheumatoid arthritis (RA) is a chronic autoinflammatory disorder which affects 
the joints.  The immune system attacks the joints causing pain and decreased mobility.  
RA is most commonly found in the elderly whereas juvenile idiopathic arthritis (JIA) is 
found in young people.  Since arthritis is an inflammatory disease, it is not surprising 
that stress can influence it.  In this case, stress can act both as a disease-permissive 
factor and a disease aggravator (Straub et al. 2005).  It is well known that acute, minor 
stressors have an immunostimulatory effect whereas major, chronic stressors have an 
immunosuppressive effect (Mawdsley et al. 2005; Straub et al. 2005).  At low cortisol 
concentrations, like those seen after stimulation with an acute stressor, production of IL-
6 and TNFα by macrophages is increased in response to lipopolysaccharide (Barber et 
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al. 1993; Mawdsley et al. 2005; Straub et al. 2005).  This type of stressor stimulates a 
pro-inflammatory response and thus may contribute to the onset of arthritis by acting as 
a disease-permissive factor (Straub et al. 2005).  This enhancement of inflammation 
within the correct autoimmune environment allows for the accommodation of this 
disease. 
Stress can also play the role of disease aggravator.  Once symptomatic arthritis 
appears, stress can contribute to the severity (Straub et al. 2005).  In the presence of 
certain stress axes defects, stress-induced aggravation can occur.  These defects include 
inadequate secretion of cortisol after stimulus, inadequate sympathetic tone after 
stimulus and a shift at the site of arthritis from β-adrenoceptors to α-adrenoceptors on 
certain immune cells such as macrophages, neutrophils and NK cells.  These defects can 
all contribute to a lack of immunosuppression and create an environment which 
promotes inflammation and aggravates arthritic disease (Straub et al. 2005). 
 
2.4.4 Mood Disorders/Depression and Learning Impairment 
Stress has been indicated as a potential contributing factor to mood disorders and 
depression.  It has been observed that during depression, the levels of a number of nerve 
growth factors are decreased in an area of the brain called the hippocampus (Duman et 
al. 2006).  The hippocampus is part of the limbic system and is involved in learning as 
well as memory storage and retrieval (Fenoglio et al. 2006).  The nerve growth factors 
involved in depression are brain-derived neurotrophic factor (BDNF), nerve growth 
factor (NGF) and neurotrophin-3 (NT-3) (Duman et al. 2006).  These all play a role in 
the survival and functioning of neurons in the CNS.  During depression, the levels of all 
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three factors are decreased in the hippocampus.  It is hypothesized that the inhibition of 
neurogenesis, due to insufficient quantities of nerve growth factors is the origin and 
cause of depression and associated behavioral symptoms (Duman et al. 2006).  Stress 
has been shown to exert the same effects on BDNF, NGF and NT-3 levels (Smith et al. 
1995; Ueyama et al. 1997; Duman et al. 2006).  In regards to BDNF, the effects of 
many types of stressors have been studied.  Forced swim stress, social isolation and 
immobilization stress are examples of what has been studied and each one has had the 
same effect:  they have all decreased the amount of BDNF in the hippocampus (Smith et 
al. 1995; Barrientos et al. 2003; Roceri et al. 2004).  This change can be mediated by 
cortisol because when animals are administered corticosterone, BDNF is decreased just 
as with stress (Smith et al. 1995; Schaaf et al. 1998).  BDNF mRNA increases after 
adrenalectomy also suggesting that cortisol is responsible for the stress-induced decrease 
(Chao et al. 1998).  However, removal of the adrenal glands does not completely block 
the effects of stress on BDNF signifying that there could be other contributing factors 
(Duman et al. 2006).  Nonetheless, there is considerable evidence to suggest that stress 
could play a role in the development of depression. 
The depression hypothesis involves stress which is experienced during 
adulthood.  Severe early life stress or stress in early childhood has much different 
consequences.  Severe stress early in the development of a child leads to impaired 
cognitive function including learning disabilities and memory problems later in life 
(Fenoglio et al. 2006).  As is often the case, acute mild stress has an enhancing effect on 
the hippocampus and its learning and memory processes whereas severe or chronic 
stress has the opposite effect (Luine et al. 1996; Fenoglio et al. 2006).  The CA3 area of 
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the hippocampus is especially affected by early life stress because it develops late 
compared to other structures in the brain.  In early post-natal hippocampal development, 
expression of CRH receptors (CRF1) is significantly higher than levels found in the 
adult hippocampus (Baram et al. 1998; Fenoglio et al. 2006).  For this reason, when the 
child is stressed early in life and CRH levels increase in the brain, the CA3 neurons of 
the hippocampus are damaged due to excitotoxicity.  High levels of CRH damage 
neurons expressing CRF1 (Baram et al. 1998).  CRH is also chronically up-regulated by 
early severe stress so that future stress responses will cause a greater CRH response 
(Fenoglio et al. 2006).  All of these early stress effects are supported by the observation 
that CRH-overexpressing mice have learning and memory impairment compared to 
normal mice and post-natal administration of CRH causes the same effects as severe 
early stress (Fenoglio et al. 2006).  Stress has a profound effect on the hippocampus.  
Mild stress can act to enhance hippocampal function but chronic or severe stress has 
detrimental effects which impair function. 
 
2.5 Immunological Effects 
As early as 1964, a link was known to exist between stress and immunity 
(Solomon et al. 1964).  Since then the effects of stress on immune function have been 
widely studied (Borysenko et al. 1982; Yang et al. 2000; Padgett et al. 2003).  It is 
important to study this link because it often leads to susceptibility to disease as in the 
case of bovine respiratory disease (BRD) in cattle (Galyean et al. 1999).  BRD can be 
caused by a primary infection with a virus, commonly bovine herpesvirus-1 (BHV-1), 
followed by a secondary bacterial infection with Mannheimia haemolytica (Lillie 1974).  
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BRD causes huge economic losses to the cattle industry every year through the loss of 
animals as well as treatment costs.  Stressors such as transportation have been associated 
with susceptibility to BRD.  Therefore, it is very important to understand the effects of 
stressors on the immune system. 
It is known that cortisol levels increase after a stressful event due to the 
activation of the HPA.  To elucidate the mechanisms of stress-induced immune 
modulation, studies to determine the effects of cortisol on certain parameters of the 
immune system were carried out (Borysenko et al. 1982; Blalock 1989; Yang et al. 
2000).  It has been observed that cortisol can inhibit the function of macrophages, 
basophils, mast cells, neutrophils and eosinophils (Borysenko et al. 1982).  
Glucocorticoids and ACTH have been shown to affect the proliferation of B- and T-
cells, cytokine production, antibody production, chemotaxis of monocytes and 
neutrophils and NK cell cytotoxicity (Blalock 1989).  Many of the effects of 
glucocorticoids occur at low concentrations within the range that can be induced by 
stress (Borysenko et al. 1982). 
Activation of the SAM axis also occurs after stress resulting in increased levels 
of epinephrine and norepinephrine.  It is known that lymphocytes have β-adrenergic 
receptors and when these receptors are stimulated by catecholamines adenylate cyclase 
is activated and cAMP is produced (Borysenko et al. 1982; Yang et al. 2000).  Increases 
of cAMP in lymphocytes increase metabolism of immature lymphocytes, which causes 
maturation of these cells.  However, cAMP inhibits mature lymphocytes (Borysenko et 
al. 1982; Yang et al. 2000).  Elevation of cAMP has also been shown to decrease 
histamine release by human basophils and decrease antibody production to sheep red 
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blood cells in mice (Borysenko et al. 1982; Yang et al. 2000).  One important 
observation to note is that in vitro treatment of peripheral blood leukocytes (PBLs) with 
catecholamines results in the inhibition of IL-12 synthesis and an increase in IL-10 
production (Elenkov et al. 1996; Yang et al. 2000; Padgett et al. 2003).  This shift in 
cytokine production causes a shift in T-helper (Th) cells from Th1 cells to Th2 cells.  
Th1 cells are involved in cell-mediated immunity whereas Th2 cells are involved in 
antibody production (Yang et al. 2000).  A shift away from a Th1 cell mediated 
response can result in increased susceptibility to viral infections (Elenkov et al. 1996).  
The same shift towards a Th2 type response and away from a Th1 type response was 
seen in healthy medical students taking exams (Marshall et al. 1998).  A decrease in 
interferon-γ (IFN- γ) and an increase in IL-10 from isolated PBMCs were observed after 
exam stress.  Exam stress was also shown to decrease NK activity, decrease PBL’s 
responses to mitogen, decrease production of IFN- γ by stimulated PBLs, and decrease 
antibody and virus-specific T-cell response to a hepatitis B vaccine (Glaser et al. 1985; 
Glaser et al. 1987; Glaser et al. 1992; Yang et al. 2000).  An increased rate of upper 
respiratory tract infection was also reported (Yang et al. 2000).  Another study took 
healthy individuals and inoculated them with five strains of live respiratory viruses 
(Cohen et al. 1991; Yang et al. 2000).  They found that those with psychological stress 
had an increased risk for developing respiratory illness.  Also, the higher the stress the 
more severe the symptoms (Cohen et al. 1991). 
In addition to studying the effects of cortisol and catcholamines on the immune 
system, some studies employ dexamethasone (DEX) to study the effects of stress on 
cattle (Pruett et al. 1987; Anderson et al. 1999).  Dexamethasone is a synthetic 
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glucocorticoid.  It has commonly been used to simulate stress-induced 
immunosuppression (Pruett et al. 1987).  Studies using DEX have found a decrease in 
antibody production as well as suppression of bovine lymphocyte proliferation (Ohmann 
et al. 1987; Pruett et al. 1987).  These results concur with the effects of glucocorticoids 
and catecholamines. 
Both the HPA and SAM axes have been shown to influence many aspects of the 
immune system.  Activation of these leads in most cases to reduced immunity and 
increased susceptibility to infection.  Bovine respiratory disease is a perfect example of 
how stress can lead to increased disease rates. 
 
2.6 Stress Indicators 
In order to properly study stressors and their effects, a valid and reliable 
indicator of stress must be determined.  Some attempts have been made to find reliable 
markers of stress.  Cortisol levels, catecholamine levels, acute phase proteins and even 
behavioral changes have all been used as ways to evaluate the stress of an individual.  
However, none of these indicators are without problems. 
 
2.6.1 Cortisol 
Since stress is known to induce the HPA and cortisol is the end product of that 
cascade, it is reasonable to assume that cortisol levels can be used to indicate stress.  An 
increase in cortisol levels has long been used to indicate stress (Beerda et al. 1996; 
Grandin 1997; Queyras et al. 2004).  Cortisol levels can be monitored in saliva, serum 
and urine (King et al. 2002).  The advantages of using cortisol as a marker include its 
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non-invasive measurement and direct connection to the stress response of the body.  It 
also has several disadvantages (Queyras et al. 2004).  Cortisol is naturally secreted in a 
diurnal rhythm.  This makes it important to consider the time of day you are sampling.  
Cortisol naturally spikes in the morning and reaches a low around midnight (Queyras et 
al. 2004).  This diurnal cycle adds some complexity to using cortisol as a marker.  
Another problem with using cortisol as a marker, is that not all types of stressors induce 
an increase in cortisol.  Weaning in cattle is an example (Hickey et al. 2003).  Clearly 
for these stressors another marker is needed for their identification.  Studies have also 
shown that there is significant inter- and intra-individual variability in cortisol levels 
suggesting that when using cortisol levels, each individual should serve as its own 
control (Queyras et al. 2004).  In addition, due to the negative feedback cortisol has on 
components of the HPA, cortisol levels can not be used to gauge long-term stressors.  
High cortisol levels can take no longer than 90 minutes to return to baseline levels 
(Queyras et al. 2004).  Increases in cortisol levels also occur very rapidly after stress.  
Taking blood from an animal results in an increase in cortisol levels in as little as two 
minutes (Queyras et al. 2004).  Cortisol increases are a good indicator of stress; 
however, the many disadvantages limit its use to specific studies.  Perhaps a marker with 
fewer disadvantages can be found. 
 
2.6.2 Catecholamines 
If cortisol is used as a marker because it is an end product of HPA induction then 
catecholamines can be used as well since they are the result of SAM activation.  Many 
stress studies include the quantification of epinephrine and norepinephrine (Lefcourt et 
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al. 1995; Loerch et al. 1999; Hickey et al. 2003).  However, catecholamines are rapidly 
eliminated from blood (Hjemdahl 1993).  They have also been shown to have a diurnal 
variation thus studies must be standardized for time of sample collection (Hjemdahl 
1993).  Plasma catecholamines represent the overall sympathetic activity and caution is 
necessary when using them to assess a condition since the organs most contributing to 
plasma levels might not be involved in the studied condition (Hjemdahl 1993).  Any 
condition activating the sympathetic nervous system would show an increase in 
catecholamines.  Therefore, they are not a specific marker of stress. 
 
2.6.3 Behavioral Changes 
Behavior of animals can be used as an indicator of stress (Queyras et al. 2004).  
Studies have shown weaning in cattle causes a predictable change in behavior such as 
increased vocalizations, more walking and less time eating and resting (Veissier et al. 
1989; Haley et al. 2005).  Branding and isolation among other stressors are known to 
cause an increase in vocalizations in cattle (Watts et al. 2000; Watts et al. 2001).  These 
changes in behavior can be used to identify stressed animals, however, not all stressors 
induce a change in behavior (Queyras et al. 2004).  Behavior is also not specific to a 
certain type of stressor; therefore additional physiological measures may be needed to 
reliably identify the effects of each type of stressor. 
Proteomics methodologies have sufficient resolution and sensitivity to identify 
candidate biomarkers for stress such as weaning stress.  Serum is a good sample 
candidate because it can represent the overall changes in physiology due to weaning and 
also it is easily obtainable.  Selection of the current experimental methodology was also 
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dictated by the fact that it should identify the indicators while introducing minimal 
artefacts and requiring no drastic treatment of the sample. Finally it was decided to 
study the global profile of water soluble proteins in serum extracted from the blood of 
experimental animals. The methodology of studying the whole protein profile of a 
system is referred to as proteomics. 
 
2.7 Proteomics Methodology 
2.7.1 The Use of Two-dimensional Gel Electrophoresis in Biomarker Discovery 
Proteomic methodologies are at the forefront of biomarker discovery (Bischoff et 
al. 2004; Thadikkaran et al. 2005).  Since changes at the transcription level do not 
necessarily correlate with changes in expression of proteins, studying the proteome 
gives a better picture of what is happening functionally in the individual (Thadikkaran et 
al. 2005).  Proteomics techniques make it easier to identify changes or differences 
between a treatment or disease and a control.  One such proteomic technique is two-
dimensional gel electrophoresis (2D-GE).  Serum, as well as other bodily fluids, can be 
analysed using this technique so less invasive sample collection is possible (Young et al. 
1995).  Its advantages include using a mixed protein sample as well as having a high 
resolving power (Young et al. 1995; Bischoff et al. 2004).  Staining of proteins in-gel 
using Coomassie G-250 stain has a detection limit of 8-10 ng (Miller et al. 2006).  Many 
studies have successfully used 2D-GE to discover novel biomarkers (Celis et al. 1999; 
Celis et al. 2000; Seliger et al. 2002).  Lately, the focus has shifted from finding a single 
biomarker to identify a disease or condition to identification of a pattern of markers.  
2D-GE allows for the discovery of a pattern of protein changes because, with this 
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technique, all proteins in the samples are analysed together (Young et al. 1995; Bischoff 
et al. 2004).  A pattern rather than a single protein allows for a more stringent 
identification with less false positives (Bischoff et al. 2004). 
2D-GE in combination with mass spectrometry (MS) facilitates the discovery of 
markers.  Improvements to MS techniques in the 1990s made rapid identification of 
separated proteins possible by comparing sequence data with database information 
(Steen et al. 2004; Thadikkaran et al. 2005).  Unlike surface enhanced laser 
desorption/ionization mass spectrometry (SELDI-MS) analysis, matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI-TOF MS) allows for the 
identification of separated proteins.  SELDI-MS can rapidly detect changes or 
differences between samples but does not provide sequence information for 
identification (Thadikkaran et al. 2005). 
 
2.7.2 Limitations 
Bischoff and Luider (2004) note several limitations of the 2D-GE technique.  
With 2D-GE, it is difficult to display the entire proteome.  Often proteins which have a 
low solubility or extremely acidic/alkaline isoelectric points will not appear on the gel.  
As well, proteins larger than 200 kDa and smaller than 10 kDa will not be displayed on 
the gel.  When analyzing serum samples, additional limitations exist.  Albumin is very 
abundant in serum and therefore is usually removed from the samples before analysis in 
human studies (Thadikkaran et al. 2005).  However, with studies involving cattle and 
other animals where the serum albumin is slightly different, standardized kits for the 
removal of human serum albumin are not optimized for the removal of bovine serum 
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albumin.  Some studies suggest that the presence of high abundance proteins such as 
albumin creates a bias towards high abundance proteins and diminishes detection of 
medium and low abundance proteins (Gygi et al. 2000).  This is a major limitation of 
2D-GE. 
MS characterization also has a major limitation.  The identification of the 
proteins of interest depends on the completeness of the protein databases used.  This 
becomes an issue when studying the bovine proteome where the protein database is no 
where near as complete as the human protein database (D'Ambrosio et al. 2005).  This 
does not limit the discovery of differences but merely limits the identification of the 
proteins involved.  Despite these limitations, 2D-GE and MS analysis are still valuable 
tools in the discovery of biomarkers as well as the study of various proteomes 
(Thadikkaran et al. 2005). 
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3.0 HYPOTHESIS AND OBJECTIVES 
 Stress has profound effects on humans and animals alike.  There are numerous 
examples of stressors identified for cattle.  These induce stress responses in the animal 
including the induction of the HPA axis and the SAM system.  They have varying 
detrimental effects on the welfare and health of cattle and have been shown to contribute 
to the susceptibility of diseases such as bovine respiratory disease.  Weaning stress is 
one component of a series of stressors which a calf encounters during its lifetime.  It is 
important to study each of these stressors and their effects in order to better prevent 
disease susceptibility and improve animal welfare.  Weaning is an example of a stressor 
which does not show an increase in cortisol levels.  An increase in cortisol levels is a 
known indicator of stress.  Since weaning stress cannot be identified using cortisol, 
another marker must be discovered.  A pattern of protein changes which are unique to 
weaning stress would make an excellent identifier.  To find these unique protein 
changes, proteomics techniques such as 2D-GE and MS were employed. 
 We hypothesize that weaning will cause sufficient stress in cattle to alter protein 
profiles in serum, which can then be used to identify this type of stress. 
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The objectives of this study were: 
 
1) To determine the effects of abrupt weaning on serum proteins by comparing 
an abrupt weaned group with a group that had never been weaned. 
2) To determine whether pre-conditioned animals have a protein profile similar 
to control animals, which have never been weaned 
3) To determine the effects of pre-conditioning by comparing this group to 
animals who have undergone abrupt weaning. 
4) To determine the effects of abrupt weaning on serum proteins over the course 
of the trial. 
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4.0 MATERIALS AND METHODS 
4.1 Clinical Parameters 
 Body weight and temperature measurements were carried out on all calves each 
time they were handled.  Body weight was measured in kilograms using a chute scale 
(Senstec 3000U).  Each calf was run through the cattle chute individually and confined 
on the scale while a measurement was taken.  Temperature was measured with a 
handheld, M500 digital rectal thermometer (GLA Electronics; CA, USA). 
 
4.2 Behavioral Observations 
 Four calves from each group were randomly chosen for behavioral observations.  
Observations were made on experimental days 1, 2 and 3 post-weaning.  Each animal 
was observed over a 10 minute period by one of two observers.  At the beginning of 
each minute, the animal’s behavior was noted.  The observer recorded which of several 
categories best described the animal’s behavior.  The available categories were:  lying 
(L), lying while ruminating (LR), standing (S), standing while ruminating (SR), eating 
(Eat), walking (W), drinking (D) and, in the case of never weaned calves only, nursing 
(N).  During each minute the number of vocalizations (VOX) made by each calf was 
also recorded.  These observations were then compared among the treatment groups.
  35
4.3 Serum Isolation from Blood 
 Approximately ten milliliters of whole blood was collected from each calf in 
serum-separator tubes (SST) (BD Vacutainer; NJ, USA) by venipuncture.  Samples 
were collected at approximately 10 AM, however due to the number of animals being 
processed, the collection time varied slightly.  Samples were also collected from animals 
in a random order each collection day.  Blood samples were allowed to stand at room 
temperature for one hour.  Serum was separated by centrifugation at 1350 x g for 10 
minutes.  Serum was collected in a clean Eppendorf tube and Protease Inhibitor Cocktail 
(Sigma-Aldrich; ON, Canada) was added (100 µl / 1 ml of serum).  Each sample was 
then separated into 100 µl aliquots and stored at -80˚C. 
 
4.4 Cortisol Concentration Assay 
 Cortisol concentration was determined by Prairie Diagnostic Services for each 
serum sample using the Immulite system (Diagnostic Products Corporation; CA, USA). 
 
4.5 Quantification and Isoelectric Focusing 
 Quantification of the protein in each serum sample was done using the Bradford 
protein assay (Bradford 1976).  Bovine serum albumin was used as a standard.  A 1:500 
dilution was made of each sample.  Twenty microlitres of diluted sample was added to 1 
ml of Bradford dye (Cat #500-0001, Bio-Rad laboratories; PA, USA), vortexed and 
incubated for 5 minutes.  Absorbance was measured using a Lambda 25 UV/VIS 
spectrometer (Perkin Elmer Instruments; Quebec, Canada) at a wavelength of 595 nm.  
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Two milligrams of serum protein was mixed with rehydration buffer [4 % (w/v) 
Chaps, 48% (w/v) urea, 1% Pharmalyte pH 3-10 (GE Healthcare; Quebec, Canada), 
0.2% (w/v) dithiothreitol and a trace of bromophenol blue in ddH2O] for a final volume 
of 250 µl and applied to 13 cm Immobiline DryStrips pH 3-10 (GE Healthcare; Quebec, 
Canada) which were allowed to rehydrate overnight.  Once rehydrated, isoelectric 
focusing was run in three steps which were:  500 V for one hour, 1000 V for one hour 
and finally 8000 V for two hours using the Ettan IPGphor II IEF system (GE 
Healthcare; Quebec, Canada).  For all three steps, current was set at 50 µA per strip at 
20 ˚C.  After IEF, the strips were equilibrated with dithiothreitol (GE Healthcare; 
Quebec, Canada) in equilibration buffer [36% (w/v) urea, 3.35% 1.5M tris pH 8.8, 
34.5% glycerol, 2% sodium dodecyl sulfate and a trace of bromophenol blue in ddH2O] 
followed by iodoacetamide (GE Healthcare; Quebec, Canada) in equilibration buffer. 
 
4.6 SDS-PAGE 
 Each strip is then placed on top of a 12% polyacrylamide gel (12% 
acrylamide/bisacrylamide solution, 25% 1.5M tris pH8.8, 0.1% sodium dodecyl sulfate, 
43.4% ddH2O, 0.05% ammonium persulfate and 0.1% temed) and run at 25 volts per gel 
for approximately 4 hours.  The gels were then fixed in a fixing solution (50% ethanol, 
2% orthophosphoric acid and 48% ddH2O) overnight followed by staining with 
Coomassie G250 stain [Bio-Rad (PA, USA); 34% Methanol, 17% (w/v) ammonium 
sulfate, 2% orthophosphoric acid, 0.1% (w/v) coomassie G250 and 62% ddH2O] for 4 
hours and destaining in 25% methanol for approximately 30 mins.  Gels were scanned 
using an Epson Expression 1680 scanner.  Images were saved as 16-bit tiff images. 
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4.7 Mass Spectrometry 
 Excised protein spots were destained in 25% methanol until the gel fragment was 
clear.  The protein samples were then treated with a reducing solution (10 mM 
dithiothreitol and 100 mM ammonium bicarbonate) followed by a blocking solution (50 
mM iodoacetamide and 100 mM ammonium bicarbonate).  Protein samples were 
digested overnight using TPCK (L-1-tosylamido-2-phenylethyl chloromethyl ketone) 
treated trypsin.  Resulting peptides were extracted three times into a 96-well plate.  
Peptide mass fingerprinting analysis of each sample was carried out on an Applied 
Biosystems Voyager DE-STR (Foster City, CA) equipped with a nitrogen laser operated 
at 337 nm with a 3 ns pulse.  The instrument was operated in positive ion reflectron 
mode.  The surface of the stainless steel MALDI plate was made hydrophobic using a 
variation of the method reported by Owen et al (2003).  The surface of the MALDI plate 
was sprayed with a commercially available hydrophobic spray (FootLocker Water and 
Stain Repellent; Foot Locker Canada, Weston ON) and allowing to dry for 15 mins.  
This was repeated four times and allowed to dry overnight.  To the prepared plate, 1.5 µl 
of α-cyano-4-hydoxycinnamic acid (CHCA) matrix (5 mg/ ml in 75% acetonitrile and 
0.1% trifluoro-acetic acid) and 5 µl of protein digest was added to a spot on the plate 
and mixed.  The spots were then allowed to dry.  Four hundred laser shots were 
averaged for each spot and then smoothed, background corrected and converted to the 
monoisotopic values with Data Explorer (Applied Biosystems; CA, USA).  The spectra 
were internally calibrated with the autolytic fragment from trypsin (MH+ 842.5100 m/z) 
when present and when not present a close external calibration was done using a mixture 
  38
of des-Arg1 Bradykinan (MH+ 904.4681 m/z) and ACTH (18-39) (MH+ 2465.1989 m/z).  
The resulting peak lists were submitted to Protein Prospector 
(http://prospector.ucsf.edu/ucsfhtml4.0/msfit.htm) for database searching. 
 
4.8 Data Analysis 
 Intensity values were obtained for each protein spot.  These values were called 
percent volumes.  The software determines the volume of each spot which is a measure 
of each spot’s intensity.  It then adds up all the spot volumes on one gel creating a total 
volume value for each gel.  Each spot volume was then divided by the total volume for 
that gel.  The result is a percent volume value for each spot on each gel.  A percent 
volume value is used for analysis because it is a way of normalizing the data.  Using a 
percent volume value enables a cross gel comparison to be made.  Each gel was run 
separately and stained independently.  Even when controlling for variables like staining 
time, differences in staining darkness may still exist.  For this reason, normalized data 
was used to make comparisons among groups or treatment days. 
 Statistical analysis was used to determine whether there were any statistically 
significant differences in the data for each comparison.  The data had a parametric trend; 
therefore, a t-test was used to determine if the treatment groups were different and a 
one-way ANOVA with a Tukey post hoc test was applied to determine which day was 
significantly different.  A one-way ANOVA was also used to detect changes over time 
within each group.  A statistically significant difference among the treatment groups or 
for the same treatment group over the days of the trial was one with a p-value of less 
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than or equal to 0.05.  Potential markers of weaning stress would be protein spots which 
were statistically different between the abrupt weaned group and the control group. 
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5.0 EXPERIMENTAL DESIGN 
5.1 Trial 1:  Method Validation 
 Two dimensional gel electrophoresis and mass spectrometry were selected as the 
methodologies of choice to address the hypothesis which states that weaning will cause 
sufficient stress to alter the serum protein profile in calves.  In order to optimize and 
determine whether changes in protein levels could be observed using these techniques, a 
small animal trial was planned.  DEX was used as an artificial means of stressing the 
calves.  The purpose of this trial was to apply a stressful condition and determine if we 
could observe any changes when compared to a control.  From this trial we obtained 
bovine serum samples which were analyzed using the two techniques.  The experimental 
design is outlined in Table 5.1. 
 On the first day of the trial (Day 0) blood was collected by venipuncture from 
three four month old calves.  This day 0 sample was our control sample.  The calves had 
not been treated with DEX at this point.  After the control sample was collected, the 
animals were injected intramuscularly with 10 mg of DEX.  Starting on day 1, blood 
was collected daily from each calf.  Serum was isolated from all blood samples collected 
during this trial.  The samples from one calf were used for optimization of the 
aforementioned two-dimensional gel electrophoresis protocol. 
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Table 5.1 Experimental timeline for Dexamethasone-treated calves 
 
Day 0 
(Control) 
Day 1 Day 2 Day 3 
• Collect blood in 
SST tubes for serum 
• Inject 10 mg 
DEX/animal 
• Collect blood in 
SST tubes for serum
 
• Collect blood in 
SST tubes for serum 
 
• Collect blood in 
SST tubes for serum
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5.2 Trial 2:  Weaning stress 
 To test our hypothesis, a weaning stress trial was planned.  Thirty cow/calf pairs 
were randomly selected from a herd.  All pairs selected were moved into one large pen 
three weeks before the trial began where they remained for the entire trial.  The three 
week adaptation period was used to eliminate or reduce the effects of other types of 
stressors such as social reorganization and change in the environment.  Cow/calf pairs 
were randomly allocated to three treatment groups:  an abrupt weaned group (AW), a 
never weaned group (NW) and a preconditioned group (PC).  Calves in the NW group 
remained with their dams throughout the entire period of the trial.  This group was an 
absolute control because they never underwent weaning.  All samples from this group 
reveal the state of calves prior to weaning.  Cows from the PC group were separated 
from their calves and the cows were removed from the pen three weeks prior to 
beginning the trial.  This was to ensure that these calves underwent weaning stress and 
then recovered prior to initiating the weaning stress trial.  This is an accepted type of 
weaning stress control (Hodgson et al. 2005).  Finally, the AW group consists of calves 
which were weaned at the beginning of the trial.  This group was undergoing weaning 
stress throughout the trial period.  Figure 5.1 is a timeline for the trial and shows when 
each of the experimental manipulations was carried out. 
From Figure 5.1, all animals including the calves and their cows were moved 
into a large pen away from the rest of the herd on day -21.  Blood for serum was 
collected from all calves at this time.  Animals were given one week to acclimatize to 
their new surroundings and peers.  Social reorganization and changes in the environment  
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Figure 5.1:  Weaning stress trial timeline.  Days are denoted along the 
timeline.  Each text box describes what was done on each day and to 
which treatment groups. 
All Groups: 
-Acclimatize 
-Serum 
All Groups: 
-Serum 
 
PC: Remove 
cows from calves 
All Groups: 
-Serum 
 
AW: 
-Remove cows 
All Groups: 
-Serum 
-21 Day: -14 0 1-3 
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are well known psychological stressors.  In this trial, we wished to study only weaning 
stress.  Therefore, it was very important to eliminate as many other stressors as possible.  
On day -14, serum was collected from all calves and the dams of the preconditioned 
group were removed from the pen to wean the calves in this group.  Note that the dams 
were removed from the pen but not the calves.  All experimental animals remained in 
the same environment throughout the entire trial.  PC calves were allowed two weeks to 
recover from being weaned.  Up until day 0, all events were part of a preparatory phase.  
Day 0 marked the beginning of the experimental phase.  On day 0, serum was collected 
from all calves and the cows of the AW calves were removed from the pen.  The calves 
of the AW group were now experiencing weaning stress and would do so for the 
remainder of the trial period.  Day 0 serum samples were considered to be control 
samples.  On this day, the AW group and the NW group were in the same state since 
weaning had not taken place for AW.  The PC group had been previously weaned and 
was now in a state after weaning stress had taken place.  On days 1 through 3, serum 
was collected daily from all calves at approximately the same time.  These samples, 
including day 0, comprised the samples for protein analysis from this trial. 
 In addition to serum, several behavioral and clinical observations were made 
daily when the calves were handled.  These measurements included body weight and 
temperature, which were used to monitor the calves for effects on weight gain or loss 
due to stress as well as fever or illness.  In the event that one or more of the calves 
developed a body temperature greater than 40.2˚C for at least two consecutive days, 
they would have been removed from the study and treated accordingly.  However, this 
never occurred.  Behavioral observations were made several hours after handling on 
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days 1, 2 and 3.  Four calves were selected randomly from each treatment group to be 
observed for behavior which included time spent lying, standing, eating, walking and 
drinking.  These behavioral observations are ones typically studied with respect to 
weaning stress.  It has been shown that there is a statistically significant difference 
between the behavior of calves prevented from nursing and those which are allowed to 
nurse (Haley et al. 2005).  All cow/calf pairs in this study were kept on rangeland 
pasture. 
 Six animals from each group were selected for proteomic analysis due to time 
and cost constraints.  Six animals from each group give sufficient power to achieve 
necessary statistical significance.  Serum collected in this trial went through a series of 
steps in analysis.  As shown in Figure 5.2, the serum was isolated from the blood 
samples and first analysed for cortisol concentration.  All samples then underwent two-
dimensional gel electrophoresis and scanned gel images were obtained.  These gel 
images were then analysed using an image analysis software (Image Master Platinum, 
GE Healthcare Biosciences, Quebec, Canada) where normalized intensity values for 
each protein were calculated.  Comparisons between each treatment group and within 
each treatment group over the days of the trial were made using the normalized intensity 
values.  Analyses were performed to determine whether any changes observed across 
groups or within groups but between days of the trial were statistically significant.  It 
was determined by frequency distribution analysis that the intensity data had an 
approximately normal distribution therefore a one-way analysis of varience (ANOVA) 
was used.  The gels from 2D-GE were also used for protein identification.  Protein spots 
were selected and excised from the gel and used for mass spectrometric analysis.  The  
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Figure 5.2:  Analysis flowchart for serum samples.  Serum 
was first isolated from the blood samples and used for 
cortisol assays to determine their cortisol concentration.  
Next two-dimensional gel electrophoresis was carried out 
using the serum to obtain gel images for analysis using 
Image master platinum software as well as mass 
spectrometric analysis.  Differential protein levels were 
obtained by comparing intensity levels calculated during 
image analysis.  Protein identification was obtained by 
using mass spectrometry data to search a protein database.  
Mascot from Matrix Science was the search engine used. 
Band 
Selection/Excision 
and Digestion 
Mass spectrometric 
characterization 
Image Analysis w/ 
Image Master 
Platinum© 
Serum
Isolation 
Cortisol 
Assays 
2D Gel 
Electrophoresis 
Protein 
Identification 
(Mascot) 
Differential 
Protein Levels
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resulting peak lists from each digested protein were compared against all protein 
databases using Mascot search engine from Matrix Science 
(http://www.matrixscience.com/) and protein identifications were made.
  48
6.0 RESULTS 
6.1 Trial 1:  Method Validation 
6.1.1 Gel Images 
 Sera collected from one calf on each of the four experimental days were used for 
two-dimensional gel electrophoresis.  Figure 6.1 shows representative gel images for 
each day of the trial.  The same two areas of each image are boxed to highlight examples 
of areas on the gels where changes in protein levels were detected over the course of the 
trial.  In box A of the control sample (day 0), there were no detectable protein spots.  
After injection of DEX, some protein spots appear on day 1 in box A.  On the second 
day after injection, more protein spots are visible in addition to those present on day 1.  
The trend continues on day 3, where even more protein spots were detected.  In box B, a 
different trend was apparent.  On day 0 there were no measurable protein spots but after 
injection, spots appear on day 1 and 2 but were no longer detectable on day 3.  By 
looking at the gel images, these qualitative observations can be made.  Quantitative 
comparisons can also be done using image analysis software. 
 
6.1.2 Quantitative Analysis 
 Normalized intensity values obtained from the scanned gel images were used to 
compare protein spots on each day of this trial.  Two areas of the gels were found to 
show changes over the course of the trial.  Figure 6.2 reports the intensity of each spot in 
box A as a percent volume value.  When comparing the values for each spot over the
  
 
 
 
 
 
 
 
 
Figure 6.1:  Gel images from animal #39 on each day of the trial.  Day 0 is a control sample taken before dexamethasone 
injection.  Days 1,2 and 3 are samples on each day following dexamethasone injection.  Boxes A and B are examples of 
areas in which a detectable difference in protein levels was observed.  Individual protein spots in each box were assigned a 
number. 
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Animal #39  Day 0 Animal #39  Day 1 Animal #39  Day 2 Animal #39  Day 3
MW (KDa) 
 
193 
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59 
 
41 
 
 
 
27 
 
20 
 
 
 
15 
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B
B 
B B
A AA 
4
3
2
1
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Figure 6.2:  Box A protein intensities from Figure 6.1.  Normalized 
intensity (y-axis) is over protein number (x-axis).  Each day is represented 
by a single bar.  Days 0 through 3 are shown for each spot in box A.  
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days of the trial, the trend was similar for all eight spots.  On day 0, the value of each 
box A protein was zero, meaning these spots were not detectable on that day.  The 
values of each spot gradually increase with each day to reach a maximum value on day 
3. 
In Figure 6.3, the four box B proteins are presented.  All proteins have an 
intensity value of zero on day 0, meaning they were not detectable on that day.  After 
injection of dexamethasone, all four proteins appear and increase in intensity from day 1 
to day 2.  On day 3 all four proteins have returned to an intensity of zero. 
 As mentioned earlier, box A and box B are representative examples of where 
changes were observed over the days of this trial.  A discussion of this trial and these 
results will follow in the discussion section. 
 
6.2 Trial 2:  Weaning Stress 
6.2.1 Body Weight and Temperature 
 The body weight of each calf in each treatment group was recorded on the days 
when samples were collected (days 0, 1, 2 and 3).  This was done to monitor the body 
weight gain or loss of each calf.  Figure 6.4 reports the body weights of each calf over 
the course of the trial.  There was no statistically significant body weight gain or loss in 
any calf irrespective of the treatment group.  There was also no statistically significant 
difference in body weight gain or loss when compared among treatment groups.  All 
calves remained at approximately the same weight throughout the course of the trial. 
 Body temperature was also measured and recorded for each calf on days that 
samples were collected.  Monitoring animals for fever and illness was very important  
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Figure 6.3:  Box B protein intensities from Figure 6.1.  Normalized intensity 
(y-axis) is over protein number (x-axis).  Each day from day 0 to day 3 is 
represented by a bar.  All protein intensities on day 0 are zero and gradually 
increase until day 2 where they peak and return back to zero on day 3. 
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Figure 6.4:  Body weight in kilograms of each calf in A) the abrupt weaned group, B) 
the never weaned group and C) the preconditioned group over the days of the trial (0, 1, 
2 and 3). Animal numbers are shown to the right of the graph.  Each line joining points 
shows the body weight trend for each animal over the course of the trial. 
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since illness is a stressor.  Had any calves developed a fever of greater than 40.2˚C for 
two consecutive days, they would have been removed from the trial.  None of the calves 
developed a fever and all remained in the study (Figure 6.5).  Animal #1 from the PC 
group had a transient increase in body temperature on day 2 (40.2˚C) and on day 3 
(40.1˚C). 
 
6.2.2 Behavioral Observations 
 Four calves were randomly chosen as representative animals from each treatment 
group and were observed for a period of ten minutes on days 1, 2 and 3.  Figure 6.6 
presents the recorded observations as an average value for all four animals in each 
group.  The y-axis represents the number of times each behavior was observed.  It is the 
mean of four animals.  Statistical analysis of the data revealed no statistical differences 
among the treatment groups or on individual days within treatment groups.  However, 
the AW group was the only group to make vocalizations.  From this data, overall it was 
not possible to differentiate between the groups. 
 
6.2.3 Serum Cortisol 
 Samples collected at approximately the same time each day from all thirty 
animals were analyzed for serum cortisol concentration.  As mentioned earlier, in the 
past an increased level of cortisol has been used as a marker for stressed individuals.  In 
Figure 6.7, the cortisol concentrations for individual animals in each group are shown 
for days 0, 1, 2 and 3.  In the AW group, there was no significant increase in cortisol 
levels after the calves were weaned.  On days 1, 2 and 3, the serum cortisol levels were 
similar when compared with the control (day 0).  There were also no differences among  
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Figure 6.5:  Body temperature in degrees Celsius for each calf in A) 
the abrupt weaned group, B) the never weaned group and C) the 
preconditioned group over the days of the trial (0, 1, 2 and 3). 
Animal numbers are shown to the right of the graph.  Each line 
joining points shows the temperature changes for each animal. 
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Figure 6.6:  Behavioral observations of each treatment group.  Types of 
behaviors monitored included VOX-vocalizations, L-lying, LR-lying 
while ruminating, S-standing, SR-standing while ruminating, Eat-eating, 
D-drinking and W-walking.  For the never weaned group N-nursing was 
added.  Behavioral observations of A) the abrupt weaned group, B) the 
never weaned group and C) the preconditioned group are shown.  Type 
of behavior is along the x-axis while the average count of each behavior 
is along the y-axis.  The results for all four animals in each treatment 
group were averaged.  Days 1, 2 and 3 are shown.  Day 1 is the first day 
after weaning of the abrupt weaned group.  SR had counts of 0 for each 
group on each day. 
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Figure 6.7:  Serum cortisol concentrations in each treatment group on days 0, 1, 2 
and 3.  Cortisol concentrations in nmol/L for A) the abrupt weaned group, B) the 
never weaned group and C) the preconditioned group are presented for individual 
animals.  The mean serum cortisol concentration for each group is denoted by a 
horizontal bar. 
Serum Cortisol Concentration
 of Abrupt Weaned Animals
0 1 2 3
0
20
40
60
80
100
120
Day
C
or
tis
ol
 (n
m
ol
/L
)
A
Serum Cortisol Concentration
of Pre-Conditioned Animals
0 1 2 3
0
20
40
60
80
100
120
Day
C
or
tis
ol
 (n
m
ol
/L
)
C 
Serum Cortisol Concentration
 of Never Weaned Animals
0 1 2 3
0
20
40
60
80
100
120
140
Day
C
or
tis
ol
 (n
m
ol
/L
)
B
  58
the experimental days (days 1, 2 and 3) and the control in either the NW group or the PC 
group.  In addition, there were no significant differences in the serum cortisol levels 
when comparing among treatment groups.  Throughout the trial, the serum cortisol 
levels remained relatively constant over time and across groups.  Six animals from each 
treatment group were selected for two-dimensional analysis on the basis of the cortisol 
data.  These six animals from each group best represented the median cortisol values in 
each group overall.  Animals which had slightly different cortisol values than the 
median were not chosen. 
 
6.2.4 Gel Images 
Two-dimensional gel electrophoresis was performed on sera samples from the 
six animals on days 0 through 3.  Day 0 is the control day and days 1 through 3 are the 
experimental days after the AW calves have been weaned.  One gel image from each 
treatment group on day 0 is shown (Figure 6.8) with the AW group represented by 
animal 104 (Panel A) the NW group is represented by animal 18 (Panel B) and the PC 
group represented by animal 78 (Panel C).  Boxes A, B and C are areas in which 
statistically significant differences were found when protein intensities were compared 
among treatment groups.  These boxed areas have been magnified to show greater detail 
in Figures 6.9, 6.10 and 6.11. 
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Figure 6.8:  Representative 2D-GE images of serum proteins for each treatment group:  A) Abrupt weaning group 
represented by animal # 74, B)  Never weaned group represented by animal #94 and C)  Pre-conditioned group represented 
by animal #54.  All images depict day 0.  Boxes A, B and C are areas in the gel images where statistically significant 
differences were identified when proteins were compared among treatment groups. 
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Figure 6.9:  Magnified region A from the three gels in Figure 6.8.  Spot 130 is 
highlighted in this box because it was statistically different among treatment 
groups.  On the left is box A from animal #74 of the AW group.  In the center is 
box A from animal #94 of the NW group.  All images depict day 0.  On the right is 
box A from animal #54 of the PC group. 
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Figure 6.10:  Magnified region B from the three gels in Figure 6.8.  All highlighted spots were statistically 
different in intensity when compared among the three treatment groups.  Box B of A) animal #74 of the AW 
group, B) animal # 94 of the NW group and C) animal #54 of the PC group is shown.  All images depict day 
0. 
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Figure 6.11:  Magnified region C from each gel in Figure 6.8.  Highlighted spots are 
those which were statistically different in intensity when compared among the three 
treatment groups.  A) box C from animal #74 of the AW group B) box C from animal 
#94 of the NW group and C) box C from animal #54 of the PC group are shown.  All 
images depict day 0. 
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6.2.5 Significant Proteins 
 Two different types of comparisons were made using the normalized intensity 
values obtained from the scanned gel images.  Protein intensities were compared among 
the three treatment groups and within groups over the course of the trial.  Statistical 
methodologies have been applied to the intensity data in order to determine if there were 
statistically significant differences in either of these two comparisons. As expected since 
the animals were selected from an outbred population, the animal to animal variation 
was high.  A one-way ANOVA takes into account both the variability within each group 
and among the groups.  In total, nine protein spots were found to be statistically 
different when either of three following comparisons were made; the AW group was 
compared with the NW group, the AW group was compared with the PC group or the 
NW group was compared with the PC group.  Seventeen protein spots were found to 
change significantly over the course of the trial when comparing within groups. 
 When comparing the protein intensities of the AW group to those of the NW 
group, two protein spots were found to be significantly different when using a one-way 
ANOVA.  The results of such analysis are outlined in Figure 6.12.  Any difference with 
a p-value of less than 0.05 was considered significant.  Spot 187 was significantly 
different in intensity on day 1 with intensity greater in the AW group than in the NW 
group.  Day 1 was the first day after the AW group was weaned.  There were no 
significant differences for this spot on days 2 and 3; therefore, this difference between 
the two treatment groups was very transient.  Spot 215 also differed on days 1 and 3, 
however the difference in intensity on day 3 was not unique to the AW group.  The 
effects on the serum proteome of weaning stress seem to only persist for one day 
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Figure 6.12:  Comparison of spot intensities for the AW and NW group.  Each graph 
represents the intensities of one protein spot.  Bars marked with * have a p-value < 
0.05. 
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after weaning.  The transient nature of this protein change would not provide a good 
biomarker for weaning stress responses since that was an issue with cortisol as well. 
 Five proteins were significantly different in intensities when the AW group and 
the PC group were compared (Figure 6.13).  Spot 130 showed a difference in intensity 
on both day 0 and day 1.  Spot 194 was significantly different on day 0 and spots 196 
and 228 were significantly different in intensities only on day 2.  Lastly, spot 244 was 
significantly greater in intensity in the AW group than in the PC group on day 1.  These 
differences between the AW and PC groups were distributed throughout the time course 
including differences on day 0.  Since the PC group was weaned much earlier than the 
AW group, differences on day 0 might be expected. 
 Figure 6.14 shows five proteins which were significantly different in intensity 
when the PC group was compared with the NW group.  Spot 194 was different only on 
day 1.  Spots 204 and 225 both were different on day 2; however, spot 225 was also 
different on day 0.  Spots 196 and 215 were different between the two groups on day 3.  
Again, all these differences in protein intensities had a very transient nature.  This 
analysis showed that the serum proteome of these two control groups, PC and NW, were 
different.  Therefore, depending on what physiological parameters are studied, the 
choice of control group is very important and may change the results of the study. 
   Statistical analysis was also performed in order to identify protein spots which 
may be changing over the course of the trial within each group.  A total of seventeen 
proteins were found to change significantly over time when analyzed within group with 
a one-way ANOVA.  A p-value of less than 0.05 is considered significant.  Two spots 
from the NW group changed significantly over the course of the trial.  Spot 209 differed 
  66
 
 
Figure 6.13:  Protein spots which were significantly different when the AW and PC 
groups were compared.  Each graph represents the intensity of one protein spot on 
days 0, 1, 2 and 3.  Bars marked with * were significantly different (p-value < 0.05). 
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Figure 6.14:  Protein spots which were significantly different when the PC and NW 
groups were compared.  Each graph represents the intensity of one protein spot on days 
0, 1, 2 and 3.  Bars marked with * were significantly different (p-value < 0.05). 
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between day 1 and day 3.  Spot 245 differed between day 2 and day 3 (Figure 6.15).  
Generally, the expectation of a control group is that it does not change over time.  
However, with regards to the serum proteome, proteins may have certain level changes 
due to natural rhythms or other bodily functions which affect these proteins.  Therefore, 
to detect changes in protein levels in the NW group does not necessarily denote 
technical error or false statistical significance.  It may, however, suggest changes 
unrelated to stress may occur.  The reason for this control group was to determine the 
natural pattern of the serum proteome and, with the AW and PC groups, to look for a 
perturbation in this control pattern.  
 Five spots changed significantly during the trial within the PC group.  Figure 
6.16 presents these five spots and where the statistical difference lies.  Spot 177 changed 
significantly between day 0 and day 3 and the intensity of spot 185 decreased 
significantly after day 0.  Spots 216 and 234 were significantly different between day 0 
and day 3 and day 0 and day 2 respectively.  For spot 244, day 1 was significantly lower 
in intensity than days 0 and 2.  There were more changes over the time course in the PC 
group than the NW group.  This was somewhat expected since the PC group was 
weaned two weeks prior to day 0 and physiological changes associated with weaning 
might still be occurring. 
 The AW group displayed the most changes in serum proteins throughout the 
trial.  Figure 6.17 reports all ten spots.  Many of the changes in protein intensities within 
this group were very transient and could be due to random differences in protein levels.  
Such was the case for spots 130, 168, 170, 177, 196 and 197.  For spot 137, there was a 
significant decrease in intensity after day 0 and this change remained constant for days 
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Figure 6.15:  Spots which changed in intensity over the course of the trial in the NW 
group.  Significant differences are marked with an *.  The mean value plus/minus 
one standard deviation is shown. 
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Figure 6.16:  Changes in spot intensity over the course of the trial in the PC group.  
Significant differences are marked with an *.  The mean value plus/minus one 
standard deviation is shown. 
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Figure 6.17:  Changes in spot intensity over the course of the trial in the AW 
group.  Significant differences are marked with an *.  The mean value plus/minus 
one standard deviation is shown. 
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1, 2 and 3.  Spot 192 also had a change in protein intensity which persisted for more 
than one day.  Spots 165 and 172 both had a change in intensity between day 0 and day 
1 which was consistent with the comparison between the groups in that the AW effects 
were seen mostly on day 1.   
 
6.2.6 Identification of Proteins 
 Mass spectrometric analysis was performed on protein spots which were 
significantly different across the treatment groups.  The search engine mascot was used 
to search the swiss prot database for matches to the mass spectrometry results.  Table 
6.1 shows the results from this mass spectrometric analysis.  Table 6.2 shows the 
estimated molecular weights and isoelectric points of each spot mentioned in the results 
section.
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Table 6.1 Identification of significantly different protein spots 
 
 
Spot IDs Predicted Protein Name 
130 Alpha-1 acid Glycoprotein 
187 Unknown 
194 Unknown 
196 Unknown 
204 Unknown 
215 Collagen alpha-1 precursor 
225 Unknown 
228 Unknown 
244 Unknown 
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Table 6.2 Estimated molecular weights and isoelectric points of significant spots 
Spot ID Estimated 
Molecular Weight 
Estimated 
Isoelectric Point 
130 37 3.3 
137 35 3.6 
165 27 3.9 
168 26 4.5 
170 27 6.5 
172 27 4.1 
177 26 3.2 
185 25 3.0 
187 25 7.5 
192 24 4.0 
194 25 9.0 
196 23 5.0 
197 23 5.2 
204 19 5.4 
209 18 5.6 
215 16 6.1 
216 15 9.0 
225 14 6.6 
228 11 5.1 
234 9 7.1 
244 5 4.3 
245 5 5.1 
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7.0 DISCUSSION AND CONCLUDING REMARKS 
7.1 Trial 1:  Method Validation 
 In order to address the hypothesis that weaning will cause sufficient stress in 
cattle to alter protein profiles in serum, traditional 2D-GE based proteomics techniques 
were chosen.  The 2D-GE technique required optimization.  A small trial was planned in 
order to determine whether changes due to DEX treatment were detectable and to 
provide samples to use when optimizing the methodology.  When comparing a sample 
from a DEX treated animal with a control sample taken before DEX injection, we found 
that with the 2D-GE technique we could detect many proteins with differing abundances 
as well as changes in protein levels across samples.  It was at this stage that a decision 
was made not to remove albumin from the serum samples.  When albumin removal was 
performed following the manufacturers instructions of the SwellGel Blue albumin 
removal kit (Pierce Biotechnology; Rockford, IL), there was also removal of other 
proteins (data not shown).  BSA functions as a transport protein, so the depletion of 
BSA may introduce artefacts through the removal of other proteins (Kragh-Hansen 
1981).  A kit for the specific removal of BSA has yet to be developed and optimized.  In 
order to detect the most proteins and changes due to treatments, albumin was not 
removed from any serum samples analyzed.  On the gel, BSA being larger in size 
remains at the top and does not interfere with the detection of lower molecular weight 
proteins.  However, the presence of BSA does reduce the sensitivity for lower 
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abundance proteins.  BSA being of high abundance reduces the amount of low 
abundance proteins being loaded into the gel since a fixed amount of total protein is 
used.  With trial one, experience with the 2D-GE technique was gained and optimization 
of reagents took place.  Changes in protein levels between a control sample and a treated 
sample were detected as well as changes in protein levels over the time course of the 
experiment were observed.  The purpose of this trial was to determine whether changes 
in serum proteins due to a specific treatment could be detected and quantified. 
 
7.2 Trial 2:  Weaning stress 
 The objectives of this project were to determine: 
  a) The effects of abrupt weaning on the serum proteome by comparing 
AW calves to a control group which had never been weaned (NW). 
b) The effects of abrupt weaning on the serum proteome by comparing 
AW calves to a control group which were previously weaned and 
allowed to recover (PC). 
c) The effects of preconditioning calves on the serum proteome by 
comparing PC calves to a control group which were never weaned (NW). 
d) The effects of abrupt weaning over the course of the trial. 
The weaning stress trial was designed to test the hypothesis that weaning will 
cause sufficient stress in cattle to alter protein profiles in serum, which can then be used 
to identify this type of stress and to address the objectives.  The trial consisted of three 
groups:  an AW group, a PC group and a NW group.  Body weight and temperature of 
each calf were monitored over the course of the trial.  Body weight was measured to 
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determine if there was a significant difference in body weight gain among the three 
treatment groups.  The AW group was expected to gain less weight than the PC group or 
the NW group, since these calves were experiencing weaning stress.  Although the PC 
group had undergone weaning stress, this group represented either the possible long 
term effects of weaning or animals which had recovered from weaning stress.  There 
was however no difference in weight gain when comparing among treatment groups.  It 
has been reported that calves which are prevented from nursing and allowed to graze 
gain less body weight than calves who are nursing (Haley et al. 2005).  Our results may 
have been due to measuring weights over a relatively short time interval during which 
the NW group did not gain a significant amount of weight.    Perhaps monitoring body 
weight over a longer interval may have revealed significant differences in weight gain.  
A larger group size may be required to detect significant differences in weight gain due 
to weaning stress.  Body temperature was also measured to determine if there were 
differences among the treatment groups and more importantly to monitor for possible 
illness.  There were no significant differences among the groups and none of the calves 
developed a fever (body temperature > 40.2˚C for two consecutive days) during the trial. 
 Behavioral observations were also recorded for four animals from each treatment 
group.  A wide range of behavioral responses were recorded but no statistical 
differences were observed among the three treatment groups.  It is noteworthy; however, 
that the AW group was the only group to vocalize during the observation period.  
Monitoring more animals in each group might be required to detect statistical 
differences.  This does not mean that there was no stress in the AW group but rather 
animal numbers were insufficient to detect the behavioral changes associated with 
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weaning stress.  It is well established that weaning causes stress and changes in behavior 
in calves (Kelley 1980; Veissier et al. 1989; Watts et al. 2000; Haley et al. 2005). 
 Serum cortisol levels have frequently been used to monitor stress responses 
(Beerda et al. 1996; Grandin 1997; Queyras et al. 2004).  It is thought that increased 
serum cortisol is an indicator of stress responses but some stressors do not induce a 
cortisolemia (Hickey et al. 2003).  Serum cortisol levels also change very rapidly and it 
is sometimes difficult and impractical to sample sufficiently often to detect this spike in 
cortisol concentration (Queyras et al. 2004).  For these reasons, cortisol may not be a 
reliable marker for stress.  Cortisol was measured daily from serum sampled in the 
morning around the same time for all animals in each treatment group and the results 
(Figure 6.7) supported the conclusion that cortisol cannot be used to identify weaning 
stress.  There were no significant differences in serum cortisol either within or among 
treatment groups.  The AW group could not be distinguished from the two control 
treatment groups (NW and PC).  This observation supports the conclusion that other 
markers for weaning stress are required.  To increase reliability of stress detection it 
may also be better to use a pattern of several markers.  In the present study, we were 
looking for a group of serum proteins which could be used to identify a weaning stress 
response. 
 The first objective of this project was to determine the effects of weaning on the 
serum protein profile of calves.  To do this, a comparison was first made between an 
AW group and a control group which has never been weaned (NW).  Through this 
comparison, there was a possibility of identifying altered protein levels which could be 
used to identify and possibly quantify a weaning stress response.  The animal to animal 
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variation was high but, two proteins were found to have significantly different levels 
when comparing the AW group and the NW group.  Both of these proteins may be good 
candidates as markers for the response to abrupt weaning.  These proteins were spot ID 
187 and 215.  Both had differences detected on day 1 however spot ID 215 also was 
different on day 3.  The concentration changes in these serum proteins on day 1 were 
unique to the AW group.  The difference of 215 on day 3 was also apparent in the 
comparison of the PC group with the NW group.  This may be an example of a long 
term effect of weaning since the PC group was weaned more than two weeks prior to 
day 3.  These specific changes were apparent in Figure 6.12 and those on day 1 did not 
appear in samples taken from either the PC or the NW groups.  Both possible marker 
proteins showed a change on day 1 post-weaning.  This observation suggests that the 
effects of weaning on the serum proteins are most profound the first day after removal 
of the dams however these changes are very transient.  Cortisol as a marker of stress 
also has a similar disadvantage. 
 To confirm the specificity of these stress biomarkers, the weaning trial should be 
repeated to determine if these two proteins consistently change following weaning 
stress.  If these changes are confirmed then it may be possible to use these proteins to 
develop a diagnostic test to identify animals that are undergoing stress.  Further work is 
required to determine the specificity of these markers to weaning stress as opposed to 
other types of stressors or physiological responses.  To increase the effectiveness of 
identifying weaning stress, both markers would be required to make an accurate 
identification.  This provides an advantage over cortisol in that there are two 
requirements for identification however both changes are still transient in nature.  These 
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biomarkers might be useful in future weaning studies to determine if a link exists 
between stress and disease susceptibility.  Once a stress response can be accurately 
identified in animals then it may be possible to study the connection between stress and 
disease. 
 A second objective for this weaning trial was to study the effects of PC animals 
in relationship to animals undergoing acute weaning stress.  A comparison was made 
between the AW group and the PC group.  The type of control group used in a study 
might influence which markers are identified to differentiate between treatments.  This 
in fact was found to be the case in this study.  All the protein markers for weaning stress 
when compared to the NW group were distinct from those when compared to the PC 
group.  The markers were dependent on which type of control group was used.  In terms 
of serum proteins, the PC group was also different from the NW group.  Five proteins 
were found to be significantly different between the AW group and the PC group.  There 
were more differences when comparing the AW group with the PC group than the NW 
group.    It may be that long term changes due to weaning are different than those after 
acute weaning. 
 The third and final objective was to determine whether the PC animals had a 
protein profile which was similar to the NW animals.  In other words, are these two 
types of controls interchangeable or are there serum proteins which may affect the 
analysis of serum protein profiles.  Five serum proteins were found to be significantly 
different in intensity.  These differences are scattered across all three days of the trial.    
These data supports the conclusion that the PC group had a serum protein profile which 
was distinct from the NW group.  This suggests that there may be some long term 
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effects of weaning.  PC groups have been used as control groups in weaning studies 
(Hodgson et al. 2005).  The choice of this control group may have implications for the 
analysis of the data. 
 Statistical analysis was also performed to analyze further the proteins which 
changed within groups during the course of the trial.  Ten proteins from the AW group 
were significantly different between two or more days of the trial.  The PC group had 5 
proteins which changed intensities over the course of the trial and the NW group had 
only two proteins which were significantly different between days of the trial.  More 
changes over time were expected in the AW group than the other groups because it was 
expected to be undergoing the greatest changes.  The NW group was a control group and 
served as a representation of normal occurrences in the serum protein profile if animals 
are not acutely stressed.  Changes over time in this group correspond to natural changes 
in protein levels.  Certain proteins, such as cortisol, are associated with a rhythmic 
pattern of secretion (Queyras et al. 2004).  Perhaps the proteins changing over time in 
the NW group also have a pattern of concentration over time.  Therefore, the serum 
protein profile of the NW group can change over time and this may not represent error 
in the 2D-GE technique.  Changes over time in the control group complicate the 
comparison with an acutely stressed group.  However, the NW group represents a 
control pattern and in order to find markers of weaning stress, perturbations of this 
control pattern are used.  Any unique changes when compared to the control pattern can 
be used as a marker.  One point to note is the fact that out of all the proteins found to be 
statistically different among the three treatment groups, only three of those proteins also 
differed in intensity during the course of the trial.  Spot IDs 130, 196 and 244 are 
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proteins which both differ among the treatment groups and between the days of the trial 
within the same group.  It is for this reason that there is more confidence in these 
proteins being true differences and not just variation.  All differences noted in the results 
section were statistically significant but independent repetition in another trial would 
further increase confidence in these results. 
 Identification of proteins which were significantly different among the treatment 
groups was carried out by mass spectrometry.  Only two proteins were identified.  These 
proteins were 130 and 215.  The low identification rate was most likely due to the lack 
of information in the bovine protein database.  Although the bovine genome is 
completely sequenced, there was not as much information for bovine proteins as for 
human or murine proteins (D'Ambrosio et al. 2005).  This makes identification of 
bovine proteins much more difficult.  Protein ID 130 was identified as alpha-1-acid 
glycoprotein (AGP).  AGP is an acute-phase protein (Fournier et al. 2000) and acute 
phase proteins increase or decrease in serum in response to injury, inflammation or 
infection (Ceron et al. 2005).  This protein was significantly increased in the PC group 
on day 0 and day 1 compared to both the AW and NW groups.  This suggests that a long 
term effect of weaning stress is an increase in AGP.  Protein ID 215 was identified as 
collagen alpha-1 precursor.  Collagen’s function is mainly structural (Gelse et al. 2003).  
This collagen precursor was increased in the AW group on day 1 compared to the NW 
group.  In the future, we may be able to identify a greater number of the significant 
proteins when the bovine protein database is more complete.  This would provide a 
better understanding of the biology surrounding the changes occurring in response to 
weaning stress. 
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 In conclusion, our hypothesis was correct.  Abrupt weaning stress altered the 
serum protein profile of calves although the variation among animals was high within all 
groups.  Many differences were also found between the protein profiles of calves 
undergoing abrupt weaning versus calves which had either undergone weaning (PC) or 
calves which have never been weaned.    These differences were statistically significant 
and the pattern of differences between a control may be used to identify calves 
undergoing abrupt weaning stress.  It was also found that different changes in serum 
proteins were identified depending upon which type of control group was used.  Thirdly, 
there were many significant differences between the PC group and the NW group.  This 
suggests that weaning had long term effects.  The differences observed between the AW 
and the PC groups demonstrate that the long term effects are different from those 
observed after acute weaning.  These two types of controls were different and this must 
be considered when planning a weaning study.  These differences may have significant 
effects on the outcome of a weaning trial when proteomics methodologies are being 
used as an analytical tool.  If differences in the serum protein profile exist, there may be 
differences in other molecules as well including metabolites.  The type of control group 
used is important and should be considered carefully. 
 In the future, this trial should be repeated to confirm the specificity of these 
protein markers.  The results of this trial may help to study weaning stress in relation to 
disease susceptibility.  It is easier to study stress if it can be reliably identified.  Perhaps 
a simple diagnostic tool could be developed to specifically identify and possibly 
quantify weaning stress in calves in other studies and potentially in the field.  Weaning 
stress can have detrimental effects on cattle.  If animals undergoing weaning stress could 
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be easily identified this may be used to design strategies to prevent disease susceptibility 
or infection.  In addition, other common stressors in cattle may also be studied in this 
manner to determine whether the protein markers identified are unique to weaning stress 
or perhaps are broadly applicable to a variety of stressors.  Weaning stress is a 
combination of psychological stress and physical (nutritional) stress.  Perhaps the next 
step in weaning research is to study these two components separately to determine their 
relative contributions.  The results of this trial are very important to the study of 
weaning stress and perhaps other stressors as well.  This study has made a contribution 
to the understanding of effects of weaning stress on the serum proteome as well as 
identifying novel biomarkers of weaning stress.  It has made a great contribution to the 
knowledge in this field and will be very useful in future weaning stress studies.
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